|
RNF38 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.96864746726533E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.07600603374658E-12 |
| Normal-vs-Stage2 |
9.44650002665526E-09 |
| Normal-vs-Stage3 |
1.63009999999408E-05 |
| Normal-vs-Stage4 |
2.41740000239687E-08 |
| Stage1-vs-Stage2 |
6.942600E-01 |
| Stage1-vs-Stage3 |
9.397200E-01 |
| Stage1-vs-Stage4 |
4.076600E-01 |
| Stage2-vs-Stage3 |
7.250000E-01 |
| Stage2-vs-Stage4 |
4.007600E-01 |
| Stage3-vs-Stage4 |
3.462400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.53286322208169E-13 |
| Normal-vs-AfricanAmerican |
1.66250002653356E-09 |
| Normal-vs-Asian |
3.65330000029473E-07 |
| Caucasian-vs-AfricanAmerican |
8.654000E-01 |
| Caucasian-vs-Asian |
4.032800E-01 |
| AfricanAmerican-vs-Asian |
2.762400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.25455201782643E-14 |
| Normal-vs-Female |
1.214350E-04 |
| Male-vs-Female |
3.613500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.9169000004845E-07 |
| Normal-vs-Extreme_Weight |
1.52822199339653E-12 |
| Normal-vs-Obese |
1.21669999963991E-07 |
| Normal-vs-Extreme_Obese |
8.93300000637254E-09 |
| Normal_Weight-vs-Extreme_Weight |
4.182000E-01 |
| Normal_Weight-vs-Obese |
4.591600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.370800E-01 |
| Extreme_Weight-vs-Obese |
7.467900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.129800E-01 |
| Obese-vs-Extreme_Obese |
1.256800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.027200E-04 |
| Normal-vs-Age(41-60Yrs) |
7.88289999942293E-08 |
| Normal-vs-Age(61-80Yrs) |
2.99760216648792E-15 |
| Normal-vs-Age(81-100Yrs) |
1.704240E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.887200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.632600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.349400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.096070E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.982800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.715000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.5109692930746E-12 |
| Normal-VS-Type2 PRCC |
1.01485486680986E-12 |
| Normal-VS-KIRP CIMP |
1.965660E-02 |
| Normal-VS-Unclassified PRCC |
8.414300E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.171200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.550400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.501800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.961600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.883700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.264000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.77315972805081E-15 |
| Normal-vs-N1 |
2.196900E-03 |
| Normal-vs-N2 |
1.84430000049751E-07 |
| N0-vs-N1 |
7.665800E-02 |
| N0-vs-N2 |
2.700800E-01 |
| N1-vs-N2 |
5.760100E-03 |
|
|
